Year
2023
-
Beyond binary: scaled molecular fingerprints for maximum diversity picking
-
FDA Approves Sanofi and Sobi’s Altuviiio for Hemophilia A
-
FDA Accepts IND and Grants Priority Review for SpringWorks Desmoid Tumors Therapeutic
-
FDA Offers Advice on Macular Degeneration Drug Trials
-
FDA’s approval of Friedreich’s ataxia drug is a game changer for treatment of rare diseases
-
Gene Therapy Consortium to Launch Rare Diseases Pilot
-
ForCast Orthopedics Gets QIDP Nod for Investigational Antibiotic
-
Exelixis Provides Update on Phase 3 CONTACT-03 Trial Evaluating Cabozantinib in Combination with Atezolizumab in Patients with Previously Treated Advanced Kidney Cancer
-
Future of generative AI in pharma
-
AstraZeneca says cancer drug Enhertu showed positive results